The Predictive Value of First Trimester Hemodynamic Parameters for Preeclampsia - DOH-Net
The Diabetes, Obesity and Hypertension in Pregnancy Research Network (DOH-Net) is a multi-disciplinary research team of obstetrical, midwifery and maternal-fetal medicine specialists.
DOH-Net, research, diabetes, hypertension, obesity, pregnancy, gestational diabetes, diabetes, obesity and hypertension in pregnancy research network, Sunnybrook Health Sciences Centre, St. Michael's Hospital, McMaster University, obstetrics, midwife, maternal-fetal medicine, specialists, researchers, Toronto, Ontario, Canada, Hamilton, Greater Toronto Area, GTA
post-template-default,single,single-post,postid-500,single-format-standard,bridge-core-3.0.5,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-29.2,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.10.0,vc_responsive

The Predictive Value of First Trimester Hemodynamic Parameters for Preeclampsia

Recent studies suggest that the cardiovascular system plays a role in the presence of preeclampsia, a pregnancy complication, in women. However there is limited information on how accurate it is in predicting the development of preeclampsia during pregnancy.  In this study, we use the Non-Invasive Cardiac System (NICaS) to measure patient’s cardiovascular and respiratory function multiple times throughout pregnancy to see how cardiac status can be used to predict the development of preeclampsia in women who are considered to be at low or high risk of developing preeclampsia. The study examines 200 women with a singleton gestation, 100 women expecting twins, and 100 pregnant women with chronic kidney disease. To observe cardiac health, two sensors connected to the device are placed on women’s wrist and ankle. The NICaS device is Health Canada approved and it is the only technology that looks at peripheral blood flow.

Contact for this study:

Isabel Arruda,